MyRNA Makes Blood-Based Lung Cancer Risk Screening More Accessible via PERKESO’s SEHATi App
MyRNA is pleased to announce that LUNGClear™, is now available on the SEHATi
MyRNA Diagnostics is establishing Malaysia’s leading miRNA-based early cancer detection platform — localising globally validated technology to improve survival through earlier intervention.
A blood-based miRNA molecular screening test designed to identify individuals at elevated risk of gastric cancer and support earlier clinical intervention.
Learn More
A blood-based miRNA risk stratification test designed to identify individuals at increased risk of lung cancer and support earlier detection strategies.
Learn MoreStay informed with our latest articles, insights, and news.
MyRNA is pleased to announce that LUNGClear™, is now available on the SEHATi
4 February 2026 Malaysia’s healthcare transformation journey is entering a critical phase—one that demands stronger integration between public healthca...
In recent years, Malaysia has made meaningful progress in strengthening its healthcare system. Yet one challenge continues to persist quietly in the b...
Let's discuss how we can help you achieve your goals with our innovative solutions.
Enquire About Partnership